VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
AstraZeneca PLC vs Pool Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisPool Corporation
POOL · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Pool Corporation's moat claims, evidence, and risks.
View POOL analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 56 / 100 for Pool Corporation).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Pool Corporation has 1 segment (100% in Wholesale distribution (pool, irrigation, outdoor living)).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Weak.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Pool Corporation has 5 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Pool Corporation
Wholesale distribution (pool, irrigation, outdoor living)
Wholesale distribution of swimming pool, irrigation/landscape, and related outdoor living products
North America (majority), with operations in Europe and Australia
Pool builders/remodelers, pool service/repair professionals, specialty pool retailers, irrigation/landscape contractors, commercial pool operators
Distributor / wholesaler
100%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
AstraZeneca PLC strengths
Pool Corporation strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Pool Corporation segments
Full profile >Wholesale distribution (pool, irrigation, outdoor living)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.